• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非酒精性脂肪性肝病作为系统性疾病的无创评估-基于机器学习的视角。

Non-invasive assessment of NAFLD as systemic disease-A machine learning perspective.

机构信息

Department of Gastroenterology, Hepatology, and Infectious Diseases, Otto-von-Guericke University Magdeburg, Magdeburg, Germany.

Department of Gastroenterology and Hepatology, University Hospital, University Duisburg-Essen, Essen, Germany.

出版信息

PLoS One. 2019 Mar 26;14(3):e0214436. doi: 10.1371/journal.pone.0214436. eCollection 2019.

DOI:10.1371/journal.pone.0214436
PMID:30913263
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6435145/
Abstract

BACKGROUND & AIMS: Current non-invasive scores for the assessment of severity of non-alcoholic fatty liver disease (NAFLD) and identification of patients with non-alcoholic steatohepatitis (NASH) have insufficient performance to be included in clinical routine. In the current study, we developed a novel machine learning approach to overcome the caveats of existing approaches.

METHODS

Non-invasive parameters were selected by an ensemble feature selection (EFS) from a retrospectively collected training cohort of 164 obese individuals (age: 43.5±10.3y; BMI: 54.1±10.1kg/m2) to develop a model able to predict the histological assessed NAFLD activity score (NAS). The model was evaluated in an independent validation cohort (122 patients, age: 45.2±11.75y, BMI: 50.8±8.61kg/m2).

RESULTS

EFS identified age, γGT, HbA1c, adiponectin, and M30 as being highly associated with NAFLD. The model reached a Spearman correlation coefficient with the NAS of 0.46 in the training cohort and was able to differentiate between NAFL (NAS≤4) and NASH (NAS>4) with an AUC of 0.73. In the independent validation cohort, an AUC of 0.7 was achieved for this separation. We further analyzed the potential of the new model for disease monitoring in an obese cohort of 38 patients under lifestyle intervention for one year. While all patients lost weight under intervention, increasing scores were observed in 15 patients. Increasing scores were associated with significantly lower absolute weight loss, lower reduction of waist circumference and basal metabolic rate.

CONCLUSIONS

A newly developed model (http://CHek.heiderlab.de) can predict presence or absence of NASH with reasonable performance. The new score could be used to detect NASH and monitor disease progression or therapy response to weight loss interventions.

摘要

背景与目的

目前用于评估非酒精性脂肪性肝病(NAFLD)严重程度和识别非酒精性脂肪性肝炎(NASH)患者的非侵入性评分方法在性能上存在不足,无法纳入临床常规。本研究采用一种新的机器学习方法来克服现有方法的局限性。

方法

通过回顾性收集的 164 名肥胖患者(年龄:43.5±10.3 岁;BMI:54.1±10.1kg/m2)的训练队列中使用集成特征选择(EFS)选择非侵入性参数,以开发一种能够预测组织学评估的 NAFLD 活动评分(NAS)的模型。在独立验证队列(122 名患者,年龄:45.2±11.75 岁,BMI:50.8±8.61kg/m2)中评估模型。

结果

EFS 确定年龄、γGT、HbA1c、脂联素和 M30 与 NAFLD 高度相关。该模型在训练队列中与 NAS 的 Spearman 相关系数为 0.46,能够区分 NAFL(NAS≤4)和 NASH(NAS>4),AUC 为 0.73。在独立验证队列中,该模型也能达到 0.7 的 AUC 值。我们进一步分析了新模型在 38 名接受生活方式干预一年的肥胖患者队列中进行疾病监测的潜力。虽然所有患者在干预下体重均有所减轻,但有 15 名患者的评分增加。评分增加与绝对体重减轻量显著降低、腰围和基础代谢率降低相关。

结论

新开发的模型(http://CHek.heiderlab.de)能够以合理的性能预测 NASH 的有无。新评分可用于检测 NASH 并监测疾病进展或对减肥干预的治疗反应。

相似文献

1
Non-invasive assessment of NAFLD as systemic disease-A machine learning perspective.非酒精性脂肪性肝病作为系统性疾病的无创评估-基于机器学习的视角。
PLoS One. 2019 Mar 26;14(3):e0214436. doi: 10.1371/journal.pone.0214436. eCollection 2019.
2
Non-alcoholic fatty liver disease - histological scoring systems: a large cohort single-center, evaluation study.非酒精性脂肪性肝病——组织学评分系统:一项大型队列单中心评估研究。
APMIS. 2017 Nov;125(11):962-973. doi: 10.1111/apm.12742.
3
Circulating lipidomic alterations in obese and non-obese subjects with non-alcoholic fatty liver disease.非酒精性脂肪性肝病肥胖和非肥胖患者循环脂质组学改变。
Aliment Pharmacol Ther. 2020 Nov;52(10):1603-1614. doi: 10.1111/apt.16066. Epub 2020 Sep 6.
4
Training of computational algorithms to predict NAFLD activity score and fibrosis stage from liver histopathology slides.训练计算算法,以从肝组织病理学幻灯片预测非酒精性脂肪性肝病活动评分和纤维化分期。
Comput Methods Programs Biomed. 2021 Aug;207:106153. doi: 10.1016/j.cmpb.2021.106153. Epub 2021 May 8.
5
Non-invasive diagnosis of non-alcoholic steatohepatitis and fibrosis with the use of omics and supervised learning: A proof of concept study.基于组学和有监督学习的非酒精性脂肪性肝炎和肝纤维化的无创诊断:概念验证研究。
Metabolism. 2019 Dec;101:154005. doi: 10.1016/j.metabol.2019.154005. Epub 2019 Nov 9.
6
Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.瘦型非酒精性脂肪性肝病患者的肝脏和心血管损伤,及其与内脏肥胖的关系。
Clin Gastroenterol Hepatol. 2017 Oct;15(10):1604-1611.e1. doi: 10.1016/j.cgh.2017.04.045. Epub 2017 May 26.
7
Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis.通过生活方式改变减轻体重可显著改善非酒精性脂肪性肝炎的特征。
Gastroenterology. 2015 Aug;149(2):367-78.e5; quiz e14-5. doi: 10.1053/j.gastro.2015.04.005. Epub 2015 Apr 10.
8
Serum cytokeratin-18 fragment levels as noninvasive marker of nonalcoholic steatohepatitis in the chilean population.血清细胞角蛋白-18片段水平作为智利人群非酒精性脂肪性肝炎的无创标志物。
Gastroenterol Hepatol. 2017 Jun-Jul;40(6):388-394. doi: 10.1016/j.gastrohep.2017.02.009. Epub 2017 Mar 28.
9
Non-invasive Evaluation of NAFLD with Indocyanine Green Clearance Test: a Preliminary Study in Morbidly Obese Patients Undergoing Bariatric Surgery.通过吲哚菁绿清除试验对非酒精性脂肪性肝病进行无创评估:对接受减肥手术的病态肥胖患者的初步研究
Obes Surg. 2018 Mar;28(3):735-742. doi: 10.1007/s11695-017-2914-0.
10
Single non-invasive model to diagnose non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).用于诊断非酒精性脂肪性肝病(NAFLD)和非酒精性脂肪性肝炎(NASH)的单一非侵入性模型。
J Gastroenterol Hepatol. 2014 Dec;29(12):2006-13. doi: 10.1111/jgh.12665.

引用本文的文献

1
Global Trends in Non-Invasive Techniques for the Diagnosis and Monitoring of Nonalcoholic Fatty Liver Disease: A Bibliometric and Visualization Analysis.非酒精性脂肪性肝病诊断与监测的非侵入性技术全球趋势:文献计量与可视化分析
J Multidiscip Healthc. 2025 Jul 26;18:4243-4266. doi: 10.2147/JMDH.S525751. eCollection 2025.
2
Machine learning models using non-invasive tests & B-mode ultrasound to predict liver-related outcomes in metabolic dysfunction-associated steatotic liver disease.使用非侵入性检测和B超预测代谢功能障碍相关脂肪性肝病肝脏相关预后的机器学习模型
Sci Rep. 2025 Jul 8;15(1):24579. doi: 10.1038/s41598-025-09288-1.
3

本文引用的文献

1
Lifestyle intervention for morbid obesity: effects on liver steatosis, inflammation, and fibrosis.生活方式干预治疗病态肥胖:对肝脏脂肪变性、炎症和纤维化的影响。
Am J Physiol Gastrointest Liver Physiol. 2018 Sep 1;315(3):G329-G338. doi: 10.1152/ajpgi.00044.2018. Epub 2018 Jun 7.
2
Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis.非酒精性脂肪性肝病、非酒精性脂肪性肝炎及相关纤维化的诊断方法。
Hepatology. 2018 Jul;68(1):349-360. doi: 10.1002/hep.29721.
3
Insulin-sensitive and insulin-resistant obese and non-obese phenotypes: role in prediction of incident pre-diabetes in a longitudinal biracial cohort.
Machine Learning-Based Non-Invasive Prediction of Metabolic Dysfunction-Associated Steatohepatitis in Obese Patients: A Retrospective Study.
基于机器学习的肥胖患者代谢功能障碍相关脂肪性肝炎的无创预测:一项回顾性研究。
Diagnostics (Basel). 2025 Apr 25;15(9):1096. doi: 10.3390/diagnostics15091096.
4
Identification of Fast Progressors Among Patients With Nonalcoholic Steatohepatitis Using Machine Learning.使用机器学习在非酒精性脂肪性肝炎患者中识别快速进展者。
Gastro Hep Adv. 2023 Sep 15;3(1):101-108. doi: 10.1016/j.gastha.2023.09.004. eCollection 2024.
5
Liver Diseases: Science, Fiction and the Foreseeable Future.肝脏疾病:科学、虚构与可预见的未来
J Pers Med. 2024 May 4;14(5):492. doi: 10.3390/jpm14050492.
6
Nonalcoholic steatohepatitis: A comprehensive updated review of risk factors, symptoms, and treatment.非酒精性脂肪性肝炎:对风险因素、症状及治疗的全面更新综述
Heliyon. 2024 Mar 25;10(7):e28468. doi: 10.1016/j.heliyon.2024.e28468. eCollection 2024 Apr 15.
7
Machine learning approaches to enhance diagnosis and staging of patients with MASLD using routinely available clinical information.利用常规临床信息的机器学习方法增强 MASLD 患者的诊断和分期。
PLoS One. 2024 Feb 29;19(2):e0299487. doi: 10.1371/journal.pone.0299487. eCollection 2024.
8
Machine learning approaches for early detection of non-alcoholic steatohepatitis based on clinical and blood parameters.基于临床和血液参数的非酒精性脂肪性肝炎早期检测的机器学习方法。
Sci Rep. 2024 Jan 30;14(1):2442. doi: 10.1038/s41598-024-51741-0.
9
Non-invasive biomarkers for liver inflammation in non-alcoholic fatty liver disease: present and future.非酒精性脂肪性肝病肝炎症的无创性生物标志物:现状与未来。
Clin Mol Hepatol. 2023 Feb;29(Suppl):S171-S183. doi: 10.3350/cmh.2022.0426. Epub 2022 Dec 12.
10
Machine Learning in Nutrition Research.机器学习在营养研究中的应用。
Adv Nutr. 2022 Dec 22;13(6):2573-2589. doi: 10.1093/advances/nmac103.
胰岛素敏感型和胰岛素抵抗型肥胖与非肥胖表型:在一个纵向双种族队列中对新发糖尿病前期预测的作用。
BMJ Open Diabetes Res Care. 2017 Jul 19;5(1):e000415. doi: 10.1136/bmjdrc-2017-000415. eCollection 2017.
4
Use of Liver Imaging and Biopsy in Clinical Practice.肝脏成像与活检在临床实践中的应用。
N Engl J Med. 2017 Aug 24;377(8):756-768. doi: 10.1056/NEJMra1610570.
5
Association Between Peripheral Adipokines and Inflammation Markers: A Systematic Review and Meta-Analysis.外周脂肪因子与炎症标志物之间的关联:一项系统评价与荟萃分析
Obesity (Silver Spring). 2017 Oct;25(10):1776-1785. doi: 10.1002/oby.21945. Epub 2017 Aug 20.
6
High-molecular weight adiponectin/HOMA-IR ratio as a biomarker of metabolic syndrome in urban multiethnic Brazilian subjects.高分子量脂联素与胰岛素抵抗指数的比值作为巴西城市多民族人群代谢综合征的生物标志物
PLoS One. 2017 Jul 26;12(7):e0180947. doi: 10.1371/journal.pone.0180947. eCollection 2017.
7
EFS: an ensemble feature selection tool implemented as R-package and web-application.EFS:一种作为R包和网络应用程序实现的集成特征选择工具。
BioData Min. 2017 Jun 27;10:21. doi: 10.1186/s13040-017-0142-8. eCollection 2017.
8
A prospective study of the utility of plasma biomarkers to diagnose alcoholic hepatitis.一项关于血浆生物标志物在诊断酒精性肝炎中的效用的前瞻性研究。
Hepatology. 2017 Aug;66(2):555-563. doi: 10.1002/hep.29080. Epub 2017 Jun 22.
9
Collaboration, Not Competition: The Role of Magnetic Resonance, Transient Elastography, and Liver Biopsy in the Diagnosis of Nonalcoholic Fatty Liver Disease.
Gastroenterology. 2017 Feb;152(3):479-481. doi: 10.1053/j.gastro.2016.12.013. Epub 2016 Dec 27.
10
Patients with ultrasound diagnosis of hepatic steatosis are at high metabolic risk.超声诊断为肝脂肪变性的患者存在高代谢风险。
Z Gastroenterol. 2016 Dec;54(12):1312-1319. doi: 10.1055/s-0042-121899. Epub 2016 Dec 9.